Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Consulting agrmnt
Director departure
Quarterly results
Appointed director
CC transcript
Inv. presentation
|
|
MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/03/2018 |
4
| Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 513 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 513 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 513 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| MAFFUID PAUL W (EXEC. VP, R AND D) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 1,735 shares
@ $0
Exercised 5,015 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 2,428 shares
@ $0
Exercised 7,021 restricted stock units
@ $0 |
|
| 04/03/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Paid exercise price by delivering 4,689 shares
@ $0
Exercised 13,561 restricted stock units
@ $0 |
|
| 02/23/2018 |
4
| Resnick Paul F (VICE PRESIDENT, CBO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 80,000 options to buy
@ $2.04, valued at
$163.2k
|
|
| 02/23/2018 |
4
| MAFFUID PAUL W (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 195,000 options to buy
@ $2.04, valued at
$397.8k
|
|
| 02/23/2018 |
4
| HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 195,000 options to buy
@ $2.04, valued at
$397.8k
|
|
| 02/23/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 290,000 options to buy
@ $2.04, valued at
$591.6k
|
|
| 02/23/2018 |
4
| Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 35,000 options to buy
@ $2.04, valued at
$71.4k
|
|
| 02/23/2018 |
4
| EISENBERG JEFFREY F (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 35,000 options to buy
@ $2.04, valued at
$71.4k
|
|
| 02/23/2018 |
4
| Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 35,000 options to buy
@ $2.04, valued at
$71.4k
|
|
| 02/23/2018 |
4
| MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 35,000 options to buy
@ $2.04, valued at
$71.4k
|
|
| 02/23/2018 |
4
| Livingston Philip O. (CHIEF SCIENCE OFFICER) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 35,000 options to buy
@ $2.04, valued at
$71.4k
|
|
| 01/24/2018 |
4
| EISENBERG JEFFREY F (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 17,444 shares
@ $0.87, valued at
$15.2k
Sold 17,998 shares
@ $0.84, valued at
$15.1k
|
|
| 01/24/2018 |
4
| Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 17,445 shares
@ $0.87, valued at
$15.2k
Sold 17,996 shares
@ $0.84, valued at
$15.1k
|
|
| 01/24/2018 |
4
| MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 17,449 shares
@ $0.87, valued at
$15.2k
Sold 17,999 shares
@ $0.84, valued at
$15.1k
|
|
| 01/24/2018 |
4
| Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 17,444 shares
@ $0.87, valued at
$15.2k
Sold 17,996 shares
@ $0.84, valued at
$15.1k
|
|
| 01/18/2018 |
4
| MAFFUID PAUL W (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 38,054 shares
@ $0.92, valued at
$35k
|
|
| 01/18/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 59,263 shares
@ $0.92, valued at
$54.5k
|
|
| 01/18/2018 |
4
| Resnick Paul F (VICE PRESIDENT, CBO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 3,071 shares
@ $0.92, valued at
$2.8k
|
|
| 01/18/2018 |
4
| HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 41,873 shares
@ $0.92, valued at
$38.5k
|
|
| 01/16/2018 |
4
| HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 66,550 shares
@ $0.96, valued at
$63.9k
Sold 38,697 shares
@ $0.98, valued at
$37.9k
Sold 11,232 shares
@ $0.96, valued at
$10.8k
Exercised 449,159 restricted stock units
@ $0 |
|
| 01/16/2018 |
4
| Resnick Paul F (VICE PRESIDENT, CBO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 4,879 shares
@ $0.96, valued at
$4.7k
Sold 2,837 shares
@ $0.98, valued at
$2.8k
Sold 824 shares
@ $0.96, valued at
$791
Exercised 29,944 restricted stock units
@ $0 |
|
| 01/16/2018 |
4
| Livingston Philip O. (CHIEF SCIENCE OFFICER) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 21,155 shares
@ $0.96, valued at
$20.3k
Sold 12,301 shares
@ $0.98, valued at
$12.1k
Sold 3,571 shares
@ $0.96, valued at
$3.4k
Exercised 100,000 restricted stock units
@ $0 |
|
| 01/16/2018 |
4
| MAFFUID PAUL W (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 60,478 shares
@ $0.96, valued at
$58.1k
Sold 35,166 shares
@ $0.98, valued at
$34.5k
Sold 10,207 shares
@ $0.96, valued at
$9.8k
Exercised 406,382 restricted stock units
@ $0 |
|
| 01/16/2018 |
4
| HANSEN JOHN DAVID (PRESIDENT AND CEO) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Sold 110,093 shares
@ $0.96, valued at
$105.7k
Sold 64,015 shares
@ $0.98, valued at
$62.7k
Sold 18,582 shares
@ $0.96, valued at
$17.8k
Exercised 727,210 restricted stock units
@ $0 |
|
| 01/12/2018 |
4
| Varvaro Thomas C (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 100,000 restricted stock units
@ $0 |
|
| 01/12/2018 |
4
| Cohen Kenneth M (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 100,000 restricted stock units
@ $0 |
|
| 01/12/2018 |
4
| EISENBERG JEFFREY F (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 100,000 restricted stock units
@ $0 |
|
| 01/12/2018 |
4
| MAIER PAUL V (Director) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Exercised 100,000 restricted stock units
@ $0 |
|
| 10/04/2017 |
4
| HANSON GREGORY P (CFO, SECR) has filed a Form 4 on MABVAX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 340,420 restricted stock units
@ $0 |
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|